rs762402071
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001382.4(DPAGT1):c.161+6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000867 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001382.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 13Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, G2P
- DPAGT1-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P
- congenital myasthenic syndromes with glycosylation defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DPAGT1 | NM_001382.4 | c.161+6C>T | splice_region_variant, intron_variant | Intron 1 of 8 | ENST00000354202.9 | NP_001373.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DPAGT1 | ENST00000354202.9 | c.161+6C>T | splice_region_variant, intron_variant | Intron 1 of 8 | 1 | NM_001382.4 | ENSP00000346142.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000439 AC: 11AN: 250324 AF XY: 0.0000517 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461688Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727152 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
DPAGT1-congenital disorder of glycosylation;C3553645:Congenital myasthenic syndrome 13 Uncertain:1
This sequence change falls in intron 1 of the DPAGT1 gene. It does not directly change the encoded amino acid sequence of the DPAGT1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs762402071, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with DPAGT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 540463). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.161+6C>T intronic alteration consists of a C to T substitution nucleotides after coding exon 1 in the DPAGT1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at